NL7905635A - Bis-(2-ammonium-2-hydroxymethyl-1,3-propaandiol)- (2r-cis)(3-methyloxiranyl)-fosfonaat; werkwijze voor de bereiding daarvan; farmaceutisch preparaat. - Google Patents
Bis-(2-ammonium-2-hydroxymethyl-1,3-propaandiol)- (2r-cis)(3-methyloxiranyl)-fosfonaat; werkwijze voor de bereiding daarvan; farmaceutisch preparaat. Download PDFInfo
- Publication number
- NL7905635A NL7905635A NL7905635A NL7905635A NL7905635A NL 7905635 A NL7905635 A NL 7905635A NL 7905635 A NL7905635 A NL 7905635A NL 7905635 A NL7905635 A NL 7905635A NL 7905635 A NL7905635 A NL 7905635A
- Authority
- NL
- Netherlands
- Prior art keywords
- cis
- preparation
- propanediol
- ammonium
- methyloxiranyl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 title claims 2
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- DYASJGUMFFSTDH-UHFFFAOYSA-N CC1OC1OP(O)=O Chemical compound CC1OC1OP(O)=O DYASJGUMFFSTDH-UHFFFAOYSA-N 0.000 claims 1
- DYASJGUMFFSTDH-STHAYSLISA-N C[C@@H]1O[C@@H]1OP(O)=O Chemical compound C[C@@H]1O[C@@H]1OP(O)=O DYASJGUMFFSTDH-STHAYSLISA-N 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 3
- YMDXZJFXQJVXBF-UHFFFAOYSA-N (2R,3S)-(3-Methyloxiranyl)phosphonic acid Natural products CC1OC1P(O)(O)=O YMDXZJFXQJVXBF-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/62—Quaternary ammonium compounds
- C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
k V07919 · ' ï i ZamBon S".p,A, I Milaan, Italië.' i bis-( 2-ammoniumr^^ydr oxymethyi-1 ,3^ropaandiolL(2E-cisL-i3-atethylox£, rany1)-fosf onaat; werkwijze voor de "bereiding daarvan; farmaceutisch.
. preparaat. . - I. - De: uitvinding heeft "betrekking op een nieuw zout van (2B-cisl— - t - - - * · -I (3-methyioxiranyl}fösfonzuur en op de "bereiding daarvan.
Meer in het "bijzonder heeft de uitvinding "betrekking op het ; bisr-(2-^ammonium-2-bydroxymethyl-1,3-propaandiol) (2E-cxs)-( 3-methyl-5· ; oxiranyl)fosfonaat met de formule van het formuleblad, en op de berei— __ ï ^ · * ’ - i .
ding daarvan. - ' - - . ! I ; - - Het (2H-cis]-{3-methyloxiranyl)fosf onzuur, dht gewoonlijk ,r j fosfomycine· wordt genoemd (Merck index 9e editie — Ut 10}y zal ook hier ‘ ' * ! A * > •metr deze naam verder· worderfeangeduid. Natrium- en calciumzouten van fos— 10 . fomycine worden alom toegepast in de mens—en.diergeneeskunde, om: de : groei van grampositieve en gramnegatieve pathogene bacteriën te renmen.
Het fosfomycinezout volgens de· uitvinding, het bIs-(2-ammo— nium-2-hydroxymethyl—1,3-propaandiol) (2E-cis) (3-metbyloxiranylïfosfonaat, is gebeten met betrekking tot verdraagbaarheid en biologische beschik- 15 baarheid aanzienlijk gunstiger te zijn dan de natrium en calciumzouten van fosfomycine. .........
\
Meer in het bijzonder is gebleken, dat de biologische beschikbaarheid van het fosfomycinezout van de uitvinding bij de mens tenminste 200/5 (d.w.z. het dubbele) bedraagt in vergelijking met die van de andere 20 zouten van fosfomycine, zowel in termen van cumulatieve urinaire terug- . winning van het actief antibioticum als in termen van het oppervlak onder de bloedspiegel versus tijdkromme. De bereiding van het fosfomycinezout volgens de uitvinding kan worden uitgevoerd volgens de algemeen in de chemie toegepaste en aan deskundigen bekende werkwijzen. Het kan bijv.
25 worden bereid door een dubbele uitwisselingsreaktie tussen het gemono— hydrateerde calciumzout van (2R-cis)-(3-methyloxiranyl)fosfonzuur en het oxalaat van 2-aminc-2-hydroxymethyl-l ,3-propaandiol.
De bereiding van het zout volgens de uitvinding wordt in een voorbeeld nader tcegelicht, door welk voorbeeld echter de uitvinding 0905635 . t. ' . ..... · .· - r · - ; ' - - 2 - . · 4 • . geenszins wordt beperkt.·
Voorbeeld
Aan 105,9 g van het monogehydr at eerde calciumzout van (2R-cis)— . (3-methyloxiranyl) fosfonzuur, gesuspendeerd in 320 cm^ water werd ge-5 leidelijk onder roeren "bij 6o°C een oplossing van 1U5 g 2-amino-2- hydroxymethyl-1,3-propaandiol en k9 g oxaalzuur in 270 cm.^ water toe--j gevoegd.. Men. liet de suspensie tot kamertemperatuur afkoelen, terwijl .men gedurende J uur "bleef roeren., Ha. gedurende een nacht "bij A°C onder roeren te· hebben, laten staan wefd de suspensie onder verminderde druk 10 . : afgefiltreerd, over Theorite 5 (merkprodukt van Seitz-Pilter-Werke voor een. filtermateriaal) en werd het filtraat drooggedampt.
; | . Het residu werd met 500 cm. absolute, ethylalkohol behandeld.
: en gedurende 1 uur al roerend onder terugvloeikoeling-gekookt..
I ·. Eet witte, kristallijne prödukt, dat zich na. koelen, afscheidde·* ! · _ f 15 .werd door filtratie onder verminderde druk. verzameld, en gedurende 10" : uur* bij 60°C onder verminderde; druk gedroogd.. Aldus verkreeg men 185 g" ; bis-C2-ammonium-2-hydroxymethyl—1, 3-propaandiol) (2E— · cis J 43-methyloxira— nyl) fosfonaat. Het smeltpunt bedroeg 1 U6~1 U8°C..
Elementair-analyse gaf de volgende resultaten: "θ ’ E F
2Q " C^HggEgO^P “ ' gevonden % 3^,55 7,6k 7,20 ·:.· ; berekend % 3k,7k 7,69 7,37 [a]^° = -3,3° (C=10$). f O 7905635
Claims (3)
1. Bis ( 2-ammonium~2-hy dr o^yrnet hy 1-1 , 3-propaandiol) (2B-cis) -(3-methyloxiranyl)fosfonaat met de formule van liet formuleblad.
2. Werkwijze voor de bereiding van bis-(2-ammonium-2-hydroxy- 5 methyl-1,3-propaandiol)(2R— cis)-(3-methyloxiranyl)fosfonaat, met het kenmerk,dat (2R-cis)-(3-methyloxiranyl)fosfonzuur of een zout daarvan in reakt'ie wordt gebracht met g-amino-2-hydroxymethyl-1,3-propaandiol . of een zout daarvan.
3. Farmaceutisch preparaat, met het kenmerk,dat dit bis- 10 (2-ammonium-2-hydr oxymethyl-1,3-pr opaandiol) (2B-cis) (3-methyloxiranyl) - fosfonaat gemengd met een of meer therapeutisch aanvaardbare bindmidde-' len, excipientia. en/of dragers bevat. i 7905635 \ *
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25853/78A IT1112282B (it) | 1978-07-19 | 1978-07-19 | Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato |
| IT2585378 | 1978-07-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7905635A true NL7905635A (nl) | 1980-01-22 |
| NL190488B NL190488B (nl) | 1993-10-18 |
| NL190488C NL190488C (nl) | 1994-03-16 |
Family
ID=11217928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7905635,A NL190488C (nl) | 1978-07-19 | 1979-07-19 | Bis(2-ammonium-2-hydroxymethyl-1,3-propaandiol)(2R-cis)-(3-methyloxiranyl)fosfonaat; werkwijze voor de bereiding daarvan; farmaceutisch preparaat. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4727065A (nl) |
| JP (1) | JPS5517381A (nl) |
| AT (1) | AT371823B (nl) |
| AU (1) | AU526464B2 (nl) |
| BE (1) | BE877286A (nl) |
| CA (1) | CA1108631A (nl) |
| CH (1) | CH640823A5 (nl) |
| DE (1) | DE2926847A1 (nl) |
| DK (1) | DK148023C (nl) |
| ES (1) | ES482268A1 (nl) |
| FR (1) | FR2431506A1 (nl) |
| GB (1) | GB2025975B (nl) |
| GR (1) | GR75071B (nl) |
| IE (1) | IE48781B1 (nl) |
| IL (1) | IL57680A (nl) |
| IT (1) | IT1112282B (nl) |
| LU (1) | LU81500A1 (nl) |
| NL (1) | NL190488C (nl) |
| SE (1) | SE440360B (nl) |
| YU (1) | YU41411B (nl) |
| ZA (1) | ZA793354B (nl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1124610B (it) * | 1979-10-18 | 1986-05-07 | Zambo Spa | Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato |
| IT1136652B (it) * | 1981-06-04 | 1986-09-03 | Crinos Industria Farmaco | Compesizione farmaceutica di fosfomicina in compresse da succhiare |
| DE3203937C2 (de) * | 1982-02-05 | 1985-10-03 | Luc Dr. 4150 Krefeld Barrut | Verfahren und Vorrichtung zum maschinellen Sanieren oder Korrigieren mindestens eines Zahnes oder zum maschinellen Vorbereiten mindestens eines Zahnes für eine festsitzende prothetische Restaurierung und zum maschinellen Herstellen der festsitzenden prothetischen Restaurierung |
| CH660305A5 (de) * | 1984-10-05 | 1987-04-15 | Schering Spa | Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren. |
| CH660306A5 (de) * | 1984-10-05 | 1987-04-15 | Schering Spa | Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren. |
| IT1231013B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'. |
| US5191094A (en) * | 1989-07-27 | 1993-03-02 | Zambon Group S.P.A. | Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing |
| ITMI20021725A1 (it) * | 2002-08-01 | 2002-10-31 | Zambon Spa | Composizioni farmaceutiche ad attivita' antibiotica. |
| EP1762573A1 (en) | 2005-09-08 | 2007-03-14 | Interquim, S.A. De C.V. | A process for the preparation of fosfomycin salts |
| ES2385158B1 (es) * | 2010-12-24 | 2013-05-28 | Arafarma Group, S.A. | Composición farmacéutica de fosfomicina |
| CN102807586B (zh) | 2012-08-31 | 2015-05-13 | 东北制药集团股份有限公司 | 磷霉素氨盐的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639590A (en) * | 1967-07-25 | 1972-02-01 | Merck & Co Inc | Antibacterial composition containing (-) (cis-1 2-epoxypropyl) phosphoric acid |
| US3641063A (en) * | 1968-01-22 | 1972-02-08 | Merck & Co Inc | Antibiotic purification process |
-
1978
- 1978-07-19 IT IT25853/78A patent/IT1112282B/it active
-
1979
- 1979-06-25 GB GB7922098A patent/GB2025975B/en not_active Expired
- 1979-06-26 BE BE0/195974A patent/BE877286A/xx not_active IP Right Cessation
- 1979-06-27 CH CH601579A patent/CH640823A5/it not_active IP Right Cessation
- 1979-06-27 IL IL57680A patent/IL57680A/xx unknown
- 1979-06-29 AU AU48552/79A patent/AU526464B2/en not_active Expired
- 1979-07-02 GR GR59481A patent/GR75071B/el unknown
- 1979-07-03 DE DE19792926847 patent/DE2926847A1/de active Granted
- 1979-07-05 ZA ZA793354A patent/ZA793354B/xx unknown
- 1979-07-05 YU YU1632/79A patent/YU41411B/xx unknown
- 1979-07-05 FR FR7917455A patent/FR2431506A1/fr active Granted
- 1979-07-06 ES ES482268A patent/ES482268A1/es not_active Expired
- 1979-07-11 AT AT0484079A patent/AT371823B/de not_active IP Right Cessation
- 1979-07-13 LU LU81500A patent/LU81500A1/xx unknown
- 1979-07-18 SE SE7906172A patent/SE440360B/sv unknown
- 1979-07-18 DK DK302379A patent/DK148023C/da not_active IP Right Cessation
- 1979-07-18 JP JP9046879A patent/JPS5517381A/ja active Granted
- 1979-07-19 CA CA332,193A patent/CA1108631A/en not_active Expired
- 1979-07-19 NL NLAANVRAGE7905635,A patent/NL190488C/nl not_active IP Right Cessation
- 1979-08-08 IE IE1366/79A patent/IE48781B1/en not_active IP Right Cessation
-
1986
- 1986-01-23 US US06/824,922 patent/US4727065A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IT1112282B (it) | 1986-01-13 |
| DK148023C (da) | 1985-07-08 |
| NL190488B (nl) | 1993-10-18 |
| FR2431506A1 (fr) | 1980-02-15 |
| AU526464B2 (en) | 1983-01-13 |
| JPS5517381A (en) | 1980-02-06 |
| GR75071B (nl) | 1984-07-13 |
| ES482268A1 (es) | 1980-04-16 |
| NL190488C (nl) | 1994-03-16 |
| LU81500A1 (fr) | 1979-10-31 |
| FR2431506B1 (nl) | 1984-11-23 |
| GB2025975B (en) | 1983-02-02 |
| IE48781B1 (en) | 1985-05-15 |
| AT371823B (de) | 1983-08-10 |
| DK148023B (da) | 1985-02-04 |
| IE791366L (en) | 1980-01-19 |
| IT7825853A0 (it) | 1978-07-19 |
| DK302379A (da) | 1980-01-20 |
| BE877286A (fr) | 1979-12-27 |
| GB2025975A (en) | 1980-01-30 |
| AU4855279A (en) | 1980-01-24 |
| ATA484079A (de) | 1982-12-15 |
| SE7906172L (nl) | 1980-01-20 |
| DE2926847C2 (nl) | 1988-11-10 |
| CH640823A5 (it) | 1984-01-31 |
| IL57680A0 (en) | 1979-10-31 |
| US4727065A (en) | 1988-02-23 |
| YU41411B (en) | 1987-04-30 |
| CA1108631A (en) | 1981-09-08 |
| ZA793354B (en) | 1980-07-30 |
| JPS6248678B2 (nl) | 1987-10-15 |
| YU163279A (en) | 1983-02-28 |
| SE440360B (sv) | 1985-07-29 |
| DE2926847A1 (de) | 1980-02-07 |
| IL57680A (en) | 1986-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7905635A (nl) | Bis-(2-ammonium-2-hydroxymethyl-1,3-propaandiol)- (2r-cis)(3-methyloxiranyl)-fosfonaat; werkwijze voor de bereiding daarvan; farmaceutisch preparaat. | |
| FI65438C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva estrar av fosfonomyrsyra | |
| EP0881225B1 (de) | Lumineszenzindikator | |
| SE463239B (sv) | Farmaceutiskt aktiva bifosfonater samt farmaceutiska kompositioner innehaallande desamma | |
| EP0108565A2 (en) | Phospholipids, their production and use thereof | |
| CA1062714A (en) | Organophosphorus compounds | |
| Andrews et al. | Hydroxypyridine and hydroxyquinoline phosphates as anti-cholinesterases | |
| US2959516A (en) | Organic phosphate compounds and use thereof | |
| Aaron et al. | The Stereochemistry of Asymmetric Phosphorus Compounds. IV. The Synthesis and Stereochemistry of Displacement Reactions of Optically Active Isopropyl Methylphosphonochloridate | |
| SU497778A3 (ru) | Способ получени эфиров тиофосфорной кислоты | |
| IL40323A (en) | Substituted pyrimidone organophosphorous derivatives and process for preparation | |
| Vinopal et al. | Selective toxicity of phoxim (phenylglyoxylonitrile oxime O, O-diethyl phosphorothioate) | |
| CA1108176A (en) | Arylalkyl and aryloxyalkyl phosphonates and preparation thereof | |
| RU2002132558A (ru) | Циклипостины, способ их получения и их применение | |
| FI67856C (fi) | Foerfarande foer framstaellning av ett antibakteriellt silversalt av fosfanilsyra | |
| US3374293A (en) | Phosphoric, phosphonic, phosphinic, thionophosphoric, -phosphonic,-phosphinic acid esters | |
| SU367107A1 (ru) | Сп(х:об получения фосфорилированных аминофенолов | |
| KR830000601B1 (ko) | 비스-(2-암모늄-2-히드록시메틸-1,3-푸로판디올)(2r-시스)-(3-메틸옥시라닐)-포스포네이트의 제조방법 | |
| SU469710A1 (ru) | Способ получени производных -алкилоксаазафосфоринанов-1,3,2 | |
| Birum et al. | Total dealkylation of esters of trivalent phosphorus and promotion of anhydride formation by N, N, N', N'-tetramethylchloroformamidinium chloride | |
| DE1768452C3 (de) | Thiophosphorsäure-O.O^-triester, Verfahren zu ihrer Herstellung und ihre Verwendung als Pestizide | |
| US4128562A (en) | Novel 3-(phosphoryloxy) and (phosphonyloxy)-thiophenes | |
| SU1159921A1 (ru) | Способ получени 4- или 5-алкилмеркаптометилфуран-2-карбоновых кислот | |
| SU606317A1 (ru) | Тринитрофенилфосфонаты, про вл ющие бактерицидную и фунгицидную активность и способ их получени | |
| Freedman et al. | The Preparation of o-Amino-Substituted Arylphosphonic Acids1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: ZAMBON GROUP S.P.A. |
|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 19990719 |